Search - tctmd.com

Displaying 821 - 840 of 881

Sort: Relevancy | Date

News Daily News

El Tratamiento con Células Madre Mejora Moderadamente la Función Cardiaca tras un IM Agudo

L.A. McKeown

March 07, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

Right Coronary CTO Forecasts Mortality After Left Main PCI

Leah Lawrence

March 06, 2012

News Daily News

El Tratamiento con Células Madre Cardíacas es Seguro y Podría Regenerar el Tejido Cardíaco

Caitlin E. Cox

March 06, 2012

News Daily News

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

Yael L. Maxwell

March 06, 2012

News Daily News

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Caitlin E. Cox

March 06, 2012

News Daily News

Renal Denervation Bonus: Improving LV Function

March 05, 2012

News Daily News

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

March 05, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Daily News

Women Benefit From TAVR as Much as Men, Maybe More

Jason Kahn

January 29, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

Studies Show Valve-in-Valve TAVR Successful for Failed Surgical Bioprostheses

L.A. McKeown

December 29, 2011

News Daily News

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

Jason Kahn

December 11, 2011

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

December 07, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

Study Looks at Surgery vs. Transcatheter Treatment for Aortic Stenosis Plus CAD

November 15, 2011

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

News Conference News

C-Pulse Heart Assist Device Improved Ventricular Remodeling, HF Symptoms

November 07, 2011

Advertisement

El Tratamiento con Células Madre Mejora Moderadamente la Función Cardiaca tras un IM Agudo

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Right Coronary CTO Forecasts Mortality After Left Main PCI

El Tratamiento con Células Madre Cardíacas es Seguro y Podría Regenerar el Tejido Cardíaco

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Renal Denervation Bonus: Improving LV Function

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Women Benefit From TAVR as Much as Men, Maybe More

Expedited Cell Therapy After STEMI Shows Promise

Studies Show Valve-in-Valve TAVR Successful for Failed Surgical Bioprostheses

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

Study Looks at Surgery vs. Transcatheter Treatment for Aortic Stenosis Plus CAD

No LateTIME Benefit for Cell Therapy After Primary PCI

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

PROTECT II: Positive Outcomes Observed with Impella Device

C-Pulse Heart Assist Device Improved Ventricular Remodeling, HF Symptoms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content